Back

Decoding Multifocal Motor Neuropathy: A Practical Guide to Diagnosis, Pathogenesis, and Emerging Innovations in Treatment

Diagnosing multifocal motor neuropathy (MMN) can be challenging, as its varied and often subtle symptoms resemble those of other neuromuscular disorders. Delayed recognition can lead to progressive motor weakness and long-term disability. Advancing knowledge of MMN pathophysiology, particularly the roles of anti-GM1 antibodies and complement activation, is paving the way for more targeted and effective treatments. Tune in for an engaging TheraTalk featuring an expert panel of neurologists and neuromuscular specialists from the US, Canada, and Europe as they explore the evolving landscape of MMN care. Through dynamic discussions, participants will gain practical, evidence-based insights into: Improving diagnostic accuracy across a wide variety of clinical presentations Understanding complement-driven disease activity and therapeutic targeting of C2 (illustrated with a 2D animation) Evaluating the safety and efficacy data for emerging therapies Expert strategies for integrating monitoring and patient-centered approaches into clinical practice. Don’t miss this opportunity to engage with experts and access exclusive clinical tools, including downloadable MMN diagnostic and clinical trial pocket guides, to support ongoing care decisions.This activity provides continuing education credits for physicians, physician assistants, nurse practitioners, pharmacists, and nurses through various accrediting agencies in the United States.International learners are encouraged to consult with their local boards and/or agencies for equivalency status.The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialties (UEMS). Additional information regarding this agreement may be found here.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 0.75 creditsAMA PRA Category 1 Credit™Up to 0.75 creditsNursingUp to 0.75 creditsPharmacyUp to 0.75 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 0.75 credits
  • Commercial Support
  • Released
    Feb 19, 2026
  • Last day to claim credit
    Feb 19, 2027 4 months left